A further paper investigated the relationship of Tau tracers’ distribution with glucose metabolism and [18F]FDG absorption, suggesting that the Tau pathology overlapped with areas of hypometabolism on the [18F]FDG PET in the brains of AD patients [65]. This evidence concerns the gene MAPT and Alzheimer disease.